Brian Shaffer

8PUBLICATIONS
70CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyNanotoxicology, health and safetyGene and molecular therapyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 15, 2026
Daratumumab therapy for refractory immune cytopenias after allogeneic hematopoietic cell transplantation.

|Jun 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.

Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan

|Jan 09, 2025
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants.

Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari

|Jan 03, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.

Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki

|Nov 20, 2024
Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: adapting Pre-MEASURE to clinical practice.

Brian C Shaffer, Partow Kebriaei, Marcos de Lima

|Nov 06, 2024
Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation.

Brian C Shaffer, Mahasweta Gooptu, Todd DeFor

Pageof 2

Frequent Collaborators

4 joint publications

Monzr M Al Malki

4 joint publications

Antonio Martin Jimenez Jimenez

3 joint publications

Steven Michael Devine

3 joint publications

Jeffery J Auletta